SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062058
Filing Date
2023-11-09
Accepted
2023-11-09 16:11:36
Documents
49
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q life-20230930.htm   iXBRL 10-Q 2265769
2 EX-31.1 life-ex31_1.htm EX-31.1 12092
3 EX-31.2 life-ex31_2.htm EX-31.2 12207
4 EX-32.1 life-ex32_1.htm EX-32.1 8498
5 EX-32.2 life-ex32_2.htm EX-32.2 7945
  Complete submission text file 0000950170-23-062058.txt   7554706

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT life-20230930_pre.xml EX-101.PRE 272322
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT life-20230930_cal.xml EX-101.CAL 49674
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT life-20230930_def.xml EX-101.DEF 166889
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT life-20230930_lab.xml EX-101.LAB 395861
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT life-20230930.xsd EX-101.SCH 43500
43 EXTRACTED XBRL INSTANCE DOCUMENT life-20230930_htm.xml XML 1305523
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 231392520
SIC: 2836 Biological Products, (No Diagnostic Substances)